MycRx
PrivateLast Round
VC Round
Nov 1, 2021
Total Funding Raised
$900,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MycRx is a biotechnology company developing oral, small molecule inhibitors that target the Myc oncoprotein for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MycRx Comparables
Compare MycRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WebenPharma | 87% | |
| Incurix | 81% | |
| Peptomyc | 78% | |
MycRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2021 |
MycRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Santé Ventures | VC Round |
| MTPConnect | Grant |
| Brandon Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 61% MoM.
- Nov 1, 2021
Funding round included Brandon Capital and Santé Ventures.
MycRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MycRx's valuation, stock price, and market status.